06/2024

News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

06/2024

Jun 23, 2024, 02:32 | Insight
Prostate Specific Antigen (PSA) Test-Program by GRACE
Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared…
Jun 23, 2024, 02:25 | Blog
Elisa Agostinetto: Important data for patients who desire pregnancy after a diagnosis of breast cancer
Elisa Agostinetto shared a post by ESMO on X/Twitter: "Are assisted reproductive techniques safe in…
Jun 23, 2024, 02:15 | Insight
New WHO report reveals four major industries are responsible for 34% of all deaths globally - UICC
Union for International Cancer Control (UICC) shared a post on LinkedIn: "New World Health Organization…
Jun 23, 2024, 01:56 | Insight
Benjamin Toll: Factors contributing to differences in cervical cancer screening
Benjamin Toll, Professor at Medical University of South Carolina, shared on X/Twitter: "Interesting article in…
Jun 22, 2024, 19:01 | Insight
Native Hawaiian and Pacific Islander populations and higher rates of inflammatory breast cancer - NCI Center for Cancer Research
NCI Center for Cancer Research shared a post on LinkedIn: “NEW FINDINGS: A CCR study…
Jun 22, 2024, 17:38 | Career
Emily Touloukian is the new Chair of the ASCO State Affiliate Council
Emily Touloukian, CEO Coastal Cancer Center, shared on LinkedIn: “Excited to start my time as…
Jun 22, 2024, 17:26 | Insight
Jennifer Lovick: Technology in cancer research and treatment editorial board
Jennifer Lovick, Executive Editor of Technology in Cancer Research and Treatment at Sage, shared a…
Jun 22, 2024, 17:06 | Drugs
FDA approves pembrolizumab with chemotherapy for advanced/recurrent endometrial carcinoma
Iván R. González, Medical Oncologist at Angeles Puebla Hospital, shared on X/Twitter: "FDA approves pembrolizumab with…
Jun 22, 2024, 16:56 | Insight
WEHI launches Ternax focused on neuroblastoma and prostrate cancer - Children's Cancer Institute
Children's Cancer Institute shared on LinkedIn:  “We send our heartfelt congratulations to WEHI (Walter and…
Jun 22, 2024, 15:13 | Drugs
Vivek Subbiah: Another FDA approval to adagrasib plus cetuximab for KRAS G12C-mutated colorectal cancer
Vivek Subbiah shared on LinkedIn: "It's Friday and time for another FDA approval! FDA grants…
All: 2742 Posts: 751 - 760
Special Coverage